People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Popular Pays, Inc. | — | Other | Series A | $11.8M | $99.9M | 2017 |
| Aveta Biomics, Inc. | — | Biotechnology | Series A | $6.2M | $24.4M | 2024 |
| Xcellerate Biotech, Inc. | — | Biotechnology | Pre-Seed | $1.1M | $36.6M | 2019 |
Peter Dolan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Dolan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Schneider | 1 | 3 |
| Parag Mehta | 1 | 1 |
| Bharat Tewarie | 1 | 1 |
| David Page | 1 | 1 |
| Guha Bala | 1 | 1 |
| Sharmila Mudgal | 1 | 1 |
| SP Kothari | 1 | 1 |
| Corbett Drummey | 1 | 1 |
| Clancey Stahr | 1 | 1 |
| John Bonhard | 1 | 1 |
| Jennifer Margaret Farver | 1 | 1 |
| S. P. Kothari | 1 | 1 |
| John Margaret Schneider | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.